Covestor’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-507
Closed -$165K 2890
2024
Q1
$165K Sell
507
-49
-9% -$12K 0.1% 243
2023
Q4
$106K Buy
556
+129
+30% +$24.4K 0.07% 461
2023
Q3
$85K Buy
427
+354
+485% +$83.7K 0.06% 520
2023
Q2
$21K Buy
73
+35
+92% +$9.72K 0.02% 1125
2023
Q1
$8K Buy
38
+1
+3% +$195 0.01% 1451
2022
Q4
$8K Sell
37
-21
-36% -$5.31K 0.01% 1449
2022
Q3
$16K Sell
58
-1
-2% -$254 0.01% 1078
2022
Q2
$11K Sell
59
-17
-22% -$3K 0.01% 1199
2022
Q1
$16K Sell
76
-234
-75% -$38.6K 0.01% 1137
2021
Q4
$55K Buy
+310
New +$61.1K 0.08% 484

Other funds holding SWAV

Covestor's SWAV Position: Q2 2024 in Review

Covestor sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 507 shares — an estimated $165K sold.

Covestor first reported a position in SWAV in Q4 2021 and held it in 10 quarters. The position peaked at $165K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Covestor reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Covestor sold 507 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $165K.
  • Covestor first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Covestor's Shockwave Medical, Inc. Common Stock position peaked at $165K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Covestor's 13F filing for Q2 2024, filed 9 Aug 2024.